Jiangsu Cancer Institute & Hospital

This study is testing if a combination of chemotherapy, low-dose radiation, and an immunotherapy drug (tislelizumab) given before and after surgery works better than chemotherapy alone for people with a certain type of advanced stomach cancer. The goal is to see if the new combin…

This study is testing whether adding two new immunotherapy drugs to standard chemotherapy (or to a different chemotherapy plus another targeted drug) can better shrink advanced ovarian tumors before surgery. The goal is to see if this approach helps more patients become eligible …

This study is testing a new combination of four drugs as the first treatment for advanced colorectal cancer that cannot be removed by surgery. It will enroll 70 patients who have not had prior cancer drug treatment. The main goal is to see how well the tumors shrink and how long …

This study is testing whether a three-part treatment given before surgery can better eliminate cancer cells in patients with operable non-small cell lung cancer. The treatment combines a short, precise course of radiation (SBRT) with two immunotherapy drugs and standard chemother…

This study aims to discover molecular markers in the blood and tumor tissue of patients with nasopharyngeal cancer. Researchers will collect samples from 60 patients before, during, and after their standard chemotherapy and radiation treatment. The goal is to find biological clue…